Rothschild Investment LLC Has $1.09 Million Position in Centene Corporation $CNC

Rothschild Investment LLC lifted its stake in shares of Centene Corporation (NYSE:CNC) by 366.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 26,519 shares of the company’s stock after acquiring an additional 20,835 shares during the period. Rothschild Investment LLC’s holdings in Centene were worth $1,091,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Oracle Investment Management Inc. acquired a new position in shares of Centene during the 3rd quarter valued at $3,936,000. Capitolis Liquid Global Markets LLC lifted its position in shares of Centene by 451.2% during the 3rd quarter. Capitolis Liquid Global Markets LLC now owns 181,900 shares of the company’s stock valued at $6,490,000 after acquiring an additional 148,900 shares during the period. Winnow Wealth LLC bought a new stake in Centene during the 3rd quarter valued at $1,100,000. Alberta Investment Management Corp increased its stake in Centene by 22.1% during the 3rd quarter. Alberta Investment Management Corp now owns 1,075,000 shares of the company’s stock valued at $38,356,000 after purchasing an additional 194,300 shares in the last quarter. Finally, Counterpoint Mutual Funds LLC increased its stake in Centene by 161.1% during the 3rd quarter. Counterpoint Mutual Funds LLC now owns 91,943 shares of the company’s stock valued at $3,281,000 after purchasing an additional 56,730 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on CNC shares. JPMorgan Chase & Co. boosted their price target on shares of Centene from $41.00 to $52.00 and gave the company a “neutral” rating in a research note on Tuesday, May 5th. Cantor Fitzgerald upgraded shares of Centene from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $41.00 to $60.00 in a research note on Tuesday, April 28th. The Goldman Sachs Group restated a “sell” rating and set a $40.00 price target on shares of Centene in a research note on Wednesday, April 29th. Barclays boosted their price target on shares of Centene from $63.00 to $75.00 and gave the company an “overweight” rating in a research note on Tuesday. Finally, Bank of America boosted their price target on shares of Centene from $60.00 to $72.00 and gave the company a “buy” rating in a research note on Thursday, May 21st. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $58.18.

Centene Stock Performance

NYSE CNC opened at $59.72 on Friday. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $60.76. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.12 and a quick ratio of 1.12. The firm has a market cap of $29.49 billion, a price-to-earnings ratio of -4.54, a PEG ratio of 0.46 and a beta of 1.06. The company has a fifty day moving average price of $45.44 and a 200-day moving average price of $42.41.

Centene (NYSE:CNC) last posted its quarterly earnings results on Tuesday, April 28th. The company reported $3.37 earnings per share for the quarter, beating the consensus estimate of $2.23 by $1.14. The company had revenue of $49.94 billion during the quarter, compared to analyst estimates of $47.53 billion. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.90 earnings per share. As a group, equities research analysts predict that Centene Corporation will post 3.45 EPS for the current fiscal year.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.